Researchers from Monash University, Cleveland Clinic, and Eli Lilly have developed an oral drug to target a form of cholesterol that has previously been untreatable and is largely caused by genetics.
In a study at the UK’s Nottingham Trent University, biomedical scientist Biola Egbowon and colleagues used nanotechnology to successfully treat macular degeneration.
The latest technology from the UC-San Francisco uses tiny electrodes implanted on the surface of the brain to detect electrical activity in the part of the brain that controls speech and face movements.
If everyone who qualified for current screening for four key forms of cancer received it, at least another 3.3 million life-years could be saved and another $1.7 trillion in economic impact added, the researchers from University of Chicago and University of Michigan find.
A new study from Lund University in Sweden has found that using AI resulted in the detection of 20% more cancers compared with standard screening, without affecting false positives.
The first doses are expected to arrive during the last quarter of the year, with rollout set to start in Benin, Burkina Faso, Burundi, Cameroon, the Democratic Republic of the Congo, Liberia, Niger, Sierra Leone and Uganda by early 2024.
A new U.K. study has found that, compared to 20 years ago, women diagnosed today with early invasive breast cancer and initially treated with surgery are 66% less likely to die from the disease.
Over the last 3 decades, Belize has achieved a dramatic reduction in its malaria burden – from a peak of about 10 000 cases in 1994 to zero indigenous cases in 2019.
The researchers from Tel Aviv University and the Sheba Medical Center at Tel Hashomer believe that their discovery could contribute to the development of a vaccine against melanoma.
The trial was so successful the U.S.’s National Cancer Institute (NCI) ordered it be halted early so that the FDA could expedite approval of the therapy to treat stage 3 and 4 Hodgkin Lymphoma.
